pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·Jul 2·1 min read
save

CDC leadership accused of stifling vaccine effectiveness studies and reshaping advisory committee role

Jul 2, 2026·read at STAT ↗RegulatoryNegative

Ben Lopman, a professor of epidemiology and global health at Emory University, wrote an opinion piece warning that CDC leadership is trying to manufacture a scientific debate about vaccines where none exists.

He points out that the agency blocked the publication of its own staff’s study on Covid‑19 vaccine effectiveness, citing methodological concerns, and that a new HHS charter for the Advisory Committee on Immunization Practices reduces the committee’s role in evaluating vaccines and shifts its focus toward alternatives.

Lopman argues that undermining the tools and surveillance networks used to measure vaccine performance could leave the United States less able to monitor the effectiveness of Covid‑19, flu, RSV vaccines and any future products, highlighting ongoing disruption within the CDC.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “Opinion: CDC leadership continues to try to manufacture a scientific debate on vaccines where none exists”

read at STAT ↗
1,238 words · retrieved Jul 2
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
Emory University4LEADING
topics
Vaccines20Vaccine19Pulmonology3AdCom2Infectious Disease2Psychiatry & CNS2NSCLCOncology

related stories

  • Apr 27New U.S. recommendation on hepatitis B vaccine will have dire consequences, studies projectSTAT
  • Jun 2910 clinical trials to watch in the second half of 2026BioPharma Dive
  • 15h agoNovartis may cut around 130 in Switzerland while relocating biologics productionBioSpace
  • 3d agoA winner, a loser, and a mid-stage signal from a major cardiology research conferenceSTAT
  • Jul 1FDA says Zyn can market its pouches as safer than cigarettesSTAT